Dr. Amaria on Genetically Modified TILs in Melanoma

1 Views
administrator
administrator
07/03/23

Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next